Lateral Flow Assays Market is projected to reach a valuation

The Lateral Flow Assays Market is anticipated to be valued at US$ 4.3 billion in 2023, growing to US$ 6.9 billion by 2033. During the forecast period, lateral flow assay sales are expected to expand at a CAGR of 4.7%.The market profited from the COVID-19 pandemic. The use of lateral flow test kits, which are smaller...

Related Keywords

New York , United States , Delaware , United Kingdom , China , , Scanwell Health Mobile App , Pharmaceuticals Biotechnology Companies , Market Insights Inc , Neumodx Molecular Inc , Roche Ltd , Thermo Fisher Scientific Inc , Quidel Corporation , Drug Development Quality Testing , Abbott Laboratories , Greater New York Chamber , Danaher Corporation , Lateral Flow Assays Market , Players Include , Scanwell Health Mobile , United States Track , Neumodx Molecular , Segments Covered , Sample Type , End User , Future Market Insights , Market Insights , Sales Channel , End Use , Sales Enquiries , All Reports ,